IP Library Granted Patent US 8,858,490
Granted Patent B2
US 8,858,490 · App. 12/834,869 · Granted Oct 14, 2014

Systems and methods for treating a carotid artery

Inventors: Tony M. Chou (Hillsborough, CA); Michi E. Garrison (Half Moon Bay, CA); Gregory M. Hyde (Menlo Park, CA); Richard Renati (Los Gatos, CA); Alan Schaer (San Jose, CA)
Assignee: Silk Road Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,858,490
App. No.
12/834,869
Granted
Oct 14, 2014
Kind
B2
Abstract

Systems and methods are adapted for treating the carotid artery. The systems include interventional catheters and blood vessel access devices that are adapted for transcervical insertion into the carotid artery. Embodiments of the systems and methods can be used in combination with embolic protection systems including blood flow reversal mechanisms, arterial filters, and arterial occlusion devices.

Claims (21)

1. A system for treating a carotid artery, comprising:

an arterial access device wherein the access device includes a distal sheath adapted to be transcervically introduced into a carotid artery through a penetration in a wall of the carotid artery;

an interventional catheter adapted for transcervical insertion into the carotid artery via the arterial access device, wherein the interventional catheter is adapted to deploy a stent;

a first hemostasis valve positioned on a proximal end of the arterial access device;

wherein the interventional catheter is formed of:

an elongated inner member having a distal region on which the stent may be mounted, the elongated inner member further having a protrusion on a proximal portion of the elongated inner member;

an elongated stent containment sheath coaxially positioned over the inner member, the stent containment sheath formed by an annular side wall, wherein an opening is formed through a proximal portion of the annular side wall of the stent containment sheath, and wherein the protrusion of the inner member extends outward through the opening such that the protrusion of the inner member may be accessed by a user at a location outside the stent containment sheath.

2. A system as in claim 1 , wherein the catheter has a working length suitable for deployment through a transcervical access sheath into the common carotid artery.

3. A system as in claim 2 , wherein the working length is within the range of approximately 40 cm to 60 cm.

4. A system as in claim 3 , wherein the working length is within the range of approximately 40 cm to 75 cm.

5. A system as in claim 1 , further comprising a second hemostasis valve positioned on a proximal region of the arterial access device.

6. A system as in claim 1 , wherein the opening in the annular side wall of the stent containment sheath is an elongated slot along which the protrusion of the inner member can be slid to achieve relative movement between the stent containment sheath and the inner member.

7. A system as in claim 1 , wherein the opening in the annular side wall of the stent containment sheath is located distal of a proximal end of the stent containment sheath.

8. A system as in claim 1 , wherein the protrusion of the inner member includes a tubular member that encircles a proximal region of the stent containment sheath.

9. A system as in claim 1 , further comprising a securement member attached to the first hemostasis valve, wherein the securement member can be actuated to engage to the protrusion on the inner member of the interventional catheter to secure the inner member to the arterial access device.

10. A system as in claim 9 , further comprising a proximal extension connected to the distal sheath and having a distal end, a proximal end, and a lumen therebetween, wherein the distal end of the proximal extension is connected to a proximal end of the distal sheath at a junction so that the lumens of each are contiguous.

11. A system as in claim 10 , wherein the distal end of the proximal extension is removably connected to a proximal end of the distal sheath at the junction.

12. A system as in claim 10 , wherein the proximal extension has a length from the junction to the first hemostasis valve sufficient to space the hemostasis valve away from the transcervical insertion site such that the exposure to radiation is minimized when the user introduces the interventional catheter into the arterial access device via the hemostasis valve while fluoroscopy is being performed in the area of the carotid artery.

13. A system as in claim 1 , further comprising a shunt fluidly connected to the arterial access device at the junction between the proximal extension and the distal sheath, wherein the shunt provides a pathway for blood to flow from the arterial access device to a return site.

14. A system as in claim 13 , wherein the arterial access device is adapted to receive blood flow from the carotid artery, and further comprising:

a flow control assembly coupled to the shunt and adapted to regulate blood flow through the shunt between at least a first blood flow state and at least a second blood flow state, wherein the flow control assembly includes one or more components that interact with the blood flow through the shunt.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2025
From: SILK ROAD MEDICAL, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 070671/0426 →
RELEASE OF SECURITY INTEREST Recorded Sep 17, 2024
From: OXFORD FINANCE, LLC
To: SILK ROAD MEDICAL, INC.
Reel/Frame 068979/0196 →
SECURITY INTEREST Recorded Jul 11, 2023
From: SILK ROAD MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 064252/0197 →
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2020
From: CRG PARTNERS III L.P.; CRG PARTNERS III - PARALLEL FUND "A" L.P.; CRG PARTNERS III - PARALLEL FUND "B" (CAYMAN) L.P.; CRG PARTNERS III (CAYMAN) L.P.
To: SILK ROAD MEDICAL, INC.
Reel/Frame 054225/0451 →
SECURITY INTEREST Recorded Oct 13, 2015
From: SILK ROAD MEDICAL, INC.
To: CRG PARTNERS III L.P.; CRG PARTNERS III - PARALLEL FUND "A" L.P.; CRG PARTNERS III - PARALLEL FUND "B" (CAYMAN) L.P.; CRG PARTNERS III (CAYMAN) L.P.
Reel/Frame 036852/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2011
From: CHOU, TONY M.; GARRISON, MICHI E.; HYDE, GREGORY M.; RENATI, RICHARD; SCHAER, ALAN
To: SILK ROAD MEDICAL, INC.
Reel/Frame 025746/0446 →
Continuity (19)
Continuation In Part 12176250 · Jul 18, 2008
Continuation In Part 12540341 · Aug 12, 2009
Continuation In Part 12357288 · Jan 21, 2009
Continuation In Part 12366287 · Feb 5, 2009
Continuation In Part 12793543 · Jun 3, 2010
Continuation In Part 12713630 · Feb 26, 2010
Provisional Application 61026308 · Feb 5, 2008
Provisional Application 60950384 · Jul 18, 2007
Provisional Application 61165392 · Mar 31, 2009
Provisional Application 61162173 · Mar 20, 2009
Provisional Application 61138403 · Dec 17, 2008
Provisional Application 61097812 · Sep 17, 2008
Provisional Application 61088680 · Aug 13, 2008
Provisional Application 61109383 · Oct 29, 2008
Provisional Application 61094797 · Sep 5, 2008
Provisional Application 61183914 · Jun 3, 2009
Provisional Application 61181588 · May 27, 2009
Provisional Application 61156367 · Feb 27, 2009
Related Publication 20110034986A1 · Feb 10, 2011